Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Retatrutide (LY3437943) is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) studied for obesity and metabolic outcomes
Retatrutide is significantly more effective than tirzepatide (Mounjaro)
It includes some heartburn medicines including proton pump inhibitors (PPIs) such as esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole, H2 blockers such as famotidine and certain diabetes medicines such as metformin
Some users prefer weekends when they can rest if side effects emerge
US$ 26.79
US$ 20.41
US$ 29.39
US$ 29.61
